4 March 2022 - Melbourne start-up Starpharma is at loggerheads with the medicines regulator over the approvals process for its COVID nasal spray, which is not available in Australia despite being widely sold overseas for more than a year.

Starpharma started developing its nasal spray Viraleze in 2020 as a preventative tool against coronavirus, to be used alongside vaccination.

Read Sydney Morning Herald article